Search Results - Moran Yang
- Showing 1 - 5 results of 5
-
1
-
2
C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer by Chen Zhang, Kankan Cao, Moran Yang, Yiying Wang, Mengdi He, Jiaqi Lu, Yan Huang, Guodong Zhang, Haiou Liu
Published in OncoImmunology (2023-12-01)Get full text
Article -
3
Siglec-9+ tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer by Yan Huang, Chen Zhang, Wei Jiang, Moran Yang, Guodong Zhang, Yiying Wang, Mengdi He, Haiou Liu, Kankan Cao
Published in Journal for ImmunoTherapy of Cancer (2023-09-01)Get full text
Article -
4
Targeting mesothelin-CD24 axis repolarizes tumor-associated macrophages to potentiate PD-1 blockade therapy in high-grade serous ovarian cancer by Moran Yang, Jiaqi Lu, Guodong Zhang, Yiying Wang, Haiou Liu, Chenyang Wang, Kankan Cao, Yujing Zhong, Xueling Wang, Xuyao Xu
Published in Journal for ImmunoTherapy of Cancer (2025-02-01)Get full text
Article -
5
Immunosuppressive JAG2+ tumor‐associated neutrophils hamper PD‐1 blockade response in ovarian cancer by mediating the differentiation of effector regulatory T cells by Chenyang Wang, Moran Yang, Yujing Zhong, Kankan Cao, Xueling Wang, Chen Zhang, Yiying Wang, Mengdi He, Jiaqi Lu, Guodong Zhang, Yan Huang, Haiou Liu
Published in Cancer Communications (2025-07-01)Get full text
Article
